RecruitingPhase III🇵🇱 PolandEN originalLung cancerMetastatic / advanced

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

This study, known as LUNAR-2, aims to investigate the effectiveness and safety of using TTFields, delivered by the NovoTTF-200T device, concomitantly administered with pembrolizumab and platinum-based chemotherapy for patients with advanced non-small cell lung cancer that has spread to other parts of the body. The primary goals of the study are to assess overall survival and progression-free survival. Secondary objectives include analyzing outcomes based on the specific histology (subtype) of the lung cancer.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • •Wiek minimum 22 lata (w USA) lub 18 lat (poza USA)
  • •Potwierdzony rozległy rak płuc, który rozprzestrzenił się na inne organy
  • •Brak poprzedniego leczenia systemowego z powodu raka przerzutowego
  • •Ogólny stan zdrowia oceniony jako dobry do prawidłowego
  • •Prawidłowe wyniki badań krwi i funkcji narządów
  • •Kobiety muszą nie być w ciąży i nie karmić piersią
  • •Mężczyźni muszą używać antykoncepcji, jeśli partner jest w wieku rozrodczym

✗ Disqualifies

  • •Mieszana postać małokomórkowego i niepłaskokomórkowego raka płuc
  • •Obecność konkretnych mutacji genetycznych, dla których dostępna jest specjalistyczna terapia
  • •Poprzednia chemioterapia na raka przerzutowego
  • •Chirurgia w ciągu ostatnich 3 tygodni
  • •Napromienianie płuc powyżej 30 Gy w ostatnich 6 miesiącach
  • •Radioterapia w ciągu ostatnich 2 tygodni

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
October 6, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (104)

Central Alabama Research

Birmingham, United States

Western Regional Medical Center, LLC

Goodyear, United States

St. Jude Herritage Medical Group

Fullerton, United States

Hoag Family Cancer Institute - Hoag Memorial Hospital

Newport Beach, United States

Sutter Institute for Medical Research

Sacramento, United States

Baptist MD Anderson Cancer Center, Baptist Health

Jacksonville, United States

Florida Cancer Affiliates - Ocala Oncology

Ocala, United States

Moffitt Cancer Center

Tampa, United States

Northwest Oncology & Hematology

Barrington, United States

Elmhurst Hospital Nancy Knowles Cancer Center

Elmhurst, United States

Edward Cancer Center

Naperville, United States

Cancer Treatment Centers of America (CTCA)

Zion, United States

Parkview Packnett Family Cancer Institute

Fort Wayne, United States

Franciscan Health Indianapolis

Indianapolis, United States

University of Kansas Cancer Center

Westwood, United States

Luminis Health Radiation Oncology - Anne Arundel Health System

Annapolis, United States

University of Kansas Cancer Center - North

Kansas City, United States

University of Kansas Cancer Center - Lee's Summit

Lee's Summit, United States

University of Kansas Cancer Center - Overland Park

Overland, United States

New York Cancer & Blood Specialists (NYCBS)

New Hyde Park, United States

New York Cancer & Blood Specialists (NYCBS)

New York, United States

University of Rochester Medical Center

Rochester, United States

New York Cancer & Blood Specialists (NYCBS)

Shirley, United States

New York Cancer & Blood Specialists (NYCBS)

The Bronx, United States

WakeMed Health & Hospitals

Cary, United States

Abramson Cancer Center

Philadelphia, United States

AHN Cancer Center

Pittsburgh, United States

Old Parkland Hospital Hematology Oncology Clinic

Dallas, United States

UT Southwestern Medical Center

Dallas, United States

DHR Health Oncology Institute

Edinburg, United States

Houston Methodist Cancer Center

Houston, United States

Methodist Richardson Cancer Center

Richardson, United States

Jason Bates at University of Texas Health Science Center

San Antonio, United States

MultiCare Regional Cancer Center

Auburn, United States

MultiCare Regional Cancer Center

Gig Harbor, United States

MultiCare Regional Cancer Center

Puyallup, United States

MultiCare Deaconess Cancer and Blood Specialty Center - Downtown

Spokane, United States

MultiCare Institute for Research & Innovation

Tacoma, United States

Universitaetsklinik fuer Innere Medizin V Innsbruck

Innsbruck, Austria

University Hospital Salzburg

Salzburg, Austria

Karl Landsteiner Institut fur Lungenforschung und pneumologische Onkologie c/o Klinik Floridsdorf

Vienna, Austria

Cliniques universitaires Saint-Luc

Brussels, Belgium

AZ Maria Middelares - Campus Maria Middelares

Ghent, Belgium

The Ottawa Hospital Cancer Centre General Campus

Ottawa, Canada

Sunnybrook Health Sciences Center

Toronto, Canada

Fakultni nemocnice Olomouc FNOL

Olomouc, Czechia

Nemocnice Agel Ostrava-Vitkovice / Agel Ostrava-Vitkovice Hospital

Ostrava, Czechia

General University Hospital in Prague

Prague, Czechia

Centre Hospitalier Intercommunal de Creteil

Créteil, France

CHU Limoges

Limoges, France

Hopital Europeen

Marseille, France

Hopital Prive du Confluent

Nantes, France

Institut Curie

Paris, France

CHU de Bordeaux

Pessac, France

Centre Hospitalier Lyon Sud

Pierre-Bénite, France

Nouvel Hopital Civil (NHC)

Strasbourg, France

Evangelische Lungenklinik Berlin

Berlin, Germany

University Hospital Giessen, ZIM IV

Giessen, Germany

Krankenhaus Martha-Maria Halle-Dolau

Halle, Germany

Thoraxklinik Heidelberg

Heidelberg, Germany

Klinik Loewenstein gGmbH

Löwenstein, Germany

Pius-Hospital Oldenburg

Oldenburg, Germany

Farkasgyepui Tudogyogyintezet

Farkasgyepű, Hungary

Bacs-Kiskun Varmegyei Oktatokorhaz

Kecskemét, Hungary

Tolna Varmegyei Balassa Janos Korhaz

Szekszárd, Hungary

Emek Medical Center

Afula, Israel

Bnai zion MC

Haifa, Israel

A.O. SS. Antonio e Biagio e Cesare Arrigo di Alessandria

Alessandria, Italy

Humanitas Gavazzeni

Bergamo, Italy

Azienda Ospedaliero-Universitaria di Ferrara - Arcispedale Sant'Anna

Ferrara, Italy

IRCCS - Istituto Romagnolo per lo Studio Dei Tumori, Dino Amadori

Meldola, Italy

Azienda Sanitaria Territoriale Pesaro Urbino

Pesaro, Italy

Universita Campus Bio-Medico di Roma (UCBM) - Policlinico Universitario

Roma, Italy

Ospedale Isola Tiberina Gemelli

Rome, Italy

Azienda Ospedaliera Universitaria Senese Policlinico Le Scotte

Siena, Italy

Kindai University Hospital

Sakai, Japan

Saitama Medical University International Medical Center

Hidaka, Japan

Juntendo University

Bunkyo, Japan

National Cancer Center Hospital

Chuo-ku, Japan

Rijnstate Ziekenhuis

Arnhem, Netherlands

Medisch Centrum Leeuwarden (MCL) - Oncologisch Centrum Leeuwarden (OCL)

Friesland, Netherlands

St. Jansdal ziekenhuis

Harderwijk, Netherlands

St Antonius Ziekenhuis

Utrecht, Netherlands

Uniwersytecki Szpital Kliniczny

Poznan, Poland

NCCS Singapore

Singapore, Singapore

Curie Oncology

Singapore, Singapore

Icon Cancer Centre Singapore (Singapore Oncology Consultants)

Singapore, Singapore

Hospital Universitario del Vinalopo

Elche, Spain

Hospital Universitario Virgen del Rocio

Seville, Spain

Clinica Mi Tres Torres Barcelona - Giromed Institute

Barcelona, Spain

Hospital Universitario de Torrejon

Torrejón de Ardoz, Spain

Institut Catala d'Oncologia

Barcelona, Spain

Hospital Universitario Arnau de Vilanova

Lleida, Spain

Clinica Universidad de Navarra (Madrid)

Madrid, Spain

Hospital Ruber Internacional

Madrid, Spain

Hospital Regional Universitario de Malaga

Málaga, Spain

Clinica Universidad de Navarra

Pamplona, Spain

Cantonal Hospital Baden

Baden, Switzerland

HFR Freiburg-Kantonsspital

Fribourg, Switzerland

Charing Cross Hospital

London, United Kingdom

University Hospitals of Leicester NHS Trust

Leicester, United Kingdom

The Royal Marsden NHS Foundation Trust

London, United Kingdom

Clatterbridge Cancer Centre - Liverpool

Liverpool, United Kingdom

The Royal Marsden NHS Foundation Trust - Sutton

Sutton, United Kingdom

Trial contact

John Vu

PRINCIPAL_INVESTIGATOR

Brian Chang

PRINCIPAL_INVESTIGATOR

Jun Zhang

PRINCIPAL_INVESTIGATOR

Garth Nicholas

PRINCIPAL_INVESTIGATOR

Susanna Cheng

PRINCIPAL_INVESTIGATOR

Thomas Egenod

PRINCIPAL_INVESTIGATOR

Cyriac Blonz

PRINCIPAL_INVESTIGATOR

Wolfgang Schuette

PRINCIPAL_INVESTIGATOR

Hidetoshi Hayashi

PRINCIPAL_INVESTIGATOR

Saitama Medical University International Medical Center

Takehito Shukuya

PRINCIPAL_INVESTIGATOR

Hidehito Horinouchi

PRINCIPAL_INVESTIGATOR

Carlos Cabrera Galvez

Miguel Fernandez de Sanmamed Gutierrez

Alessandra Curioni-Fontecedro

PRINCIPAL_INVESTIGATOR

Waleed Mohammed

PRINCIPAL_INVESTIGATOR

Sean Dulloo

PRINCIPAL_INVESTIGATOR

Carles Escriu

PRINCIPAL_INVESTIGATOR

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/7/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.